ABC | Volume 112, Nº5, May 2019

Guideline Brazilian Fetal Cardiology Guidelines – 2019 Arq Bras Cardiol. 2019; 112(5):600-648 21. Clur SA, Ottenkamp J, Bilardo CM. The nuchal translucency and the fetal heart: a literature review. Prenat Diagn. 2009:29(8):739-48. 22. Ghi T, Huggon IC, Zosmer N, Nicolaides KH. Incidence of major structural cardiac defects associatedwith increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol. 2001;18(6):610-4. 23. Simpson LL, Malone FD, Bianchi DW, Ball RH, NybergDA, Comstock CH, et al. Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol. 2007;109(2 Pt 1):376-83. 24. Lopes LM, Brizot ML, Lopes MA, Ayello VD, Schultz R, Zugaib M. Structural and functional cardiac abnormalities identified prior to 16 weeks’ gestation in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol. 2003;22(5):470-8. 25. Lopes LM. (editor). Ecocardiografia fetal. Rio de Janeiro: Revinter; 2016. p. 35-65. 26. Hoffman JI, Christianson R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol. 1978;42(4):641-7. 27. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J AmColl Cardiol. 2002;39(12):1890-900. 28. Hoffman JI. The incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol. 1995;16(4):155-65. 29. Ferencz C, Rubin JD, McCarter RJ, Brenner JI, Neill CA, Perry LW, et al. Congenital heart disease: prevalance at livebirth: the Baltimore- Washington Infant Study. Am J Epidemiol. 1985;121(1):31-6. 30. Copel JA, Pilu G, Kleinman CS. Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography. Am J Obstet Gynecol. 1986:154(5):1121-32. 31. Yoon PW, Olney RS, Khoury MJ, Sappenfield WM, Chavez GF, Taylor D. Contribution of birth defects and genetic diseases to pediatric hospitallizations: a population-based study. Arch Pediatr Adolesc Med. 1997;151(11):1096-103. 32. Pinto Junior VC, Daher CV, Sallum FS, Jatene MB, Croti UA. The situation of congenital heart surgeries in Brazil. Braz J Cardiovasc Surg. 2004;19(2):III-VI. 33. Brasil. Ministério da Saúde. Sistema de informações hospitalares do SUS (SIH/SUS). Brasília; 2013. 34. Pinto Junior VC, Rodrigues LC, Muniz CR. Reflexions about formulation of politics forattentiontocardiovascularpediatrics inBrazil.Braz JCardiovasc Surg. 2009;24(1):73-80. 35. UNICEF & United Nations. Child Mortality Report 2015. [Cited in 2017 Jun 15]. Available from: https://www.unicef.org/publications/files/ child_mortality_report_web_8_sep_2015. 36. Brasil. Ministério da Saúde. Sistema de informações de nascidos vi- vos/ MS/SVS/DASIS. Informações de saúde. Nascidos vivos. 2013. [Citado em 2015 Jun 14]. Disponível em: <http://tabnet.datasus.gov.br/cgi/tabcgi. exe?sinasc/cnv/nvuf. def 37. Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH. Fetal cardiac abnormalities identified prior to 14 weeks’ gestation. Ultrasound Obstet Gynecol. 2002;20(1):22-9. 38. Taipale P, AmmäläM, Salonen R, Hiilesmaa V. Two-stage ultrasonography in screening for fetal anomalies at 13-14 and 18-22 weeks of gestation. Acta Obstet Gynecol Scand. 2004;83(12):1141-6. 39. GembruchU, Geipel A. Indications for fetal ecohocardiography: screening in low- and high-risk populations. In: Yagel S, SilvermanNH, GembruchU. Fetal cardiology. 2 nd ed. New York; Informa Healthcare; 2009. p. 111-29. 40. Garne E, Hansen AV, Birkelund AS, Anderson AM. Major congenital anomalies in a Danish region. Dan Med J. 2014;61(6):A4825. 41. DonofrioMT, Levy RJ, Schuette JJ, Skurow-Todd K, StenMB, Stallings C, et al. Specialized delivery room planning for fetuses with critical congenital heart disease. Am J Cardiol. 2013;111(5):737-47. 42. Roman KS, Fouron JC, Nii M, Smallhorn JF, Chaturvedi R, Jaeggi ET. Determinants of outcome in fetal pulmonary valve stenosis or atresia with intact ventricular septum. Am J Cardiol. 2007;99(5):699-703. 43. Hornberger LK, SahnDJ, Kleinman CS, Copel JA, Reed KL. Tricuspid valve disease with significant tricuspid insufficiency in the fetus: diagnosis and outcome. J Am Coll Cardiol. 1991;17(1):167-73. 44. Vogel M, McElhinney DB, Wilkins-Haug LE, Marshall AC, Benson CB, Juraszek AL, et al. Aortic stenosis and severe mitral regurgitation in the fetusresulting ingiant leftatriumandhydrops:pathophysiology,outcomes, and preliminary experience with pre-natal cardiac intervention. J AmColl Cardiol. 2011;57(3):348-55. 45. TaketazuM,BarreaC,Smallhorn JF,WilsonGJ,HornbergerLK. Intrauterine pulmonary venous flow and restrictive foramen ovale in fetal hypoplastic left heart syndrome. J Am Coll Cardiol. 2004;43(10):1902-7. 46. Sivasankaran S, Sharland GK, Simpson JM. Dilated cardiomyopathy presenting during fetal life. Cardiol Young. 2005;15(4):409-16. 47. Pedra SR, Smallhorn JF, Ryan G, Chitayat D, Taylor GP, Khan R, et al. Fetal cardiomyopathies: pathogenicmechanisms, hemodynamic findings, and clinical outcome. Circulation. 2002;106(5):585-91. 48. Hornberger LK, Sahn DJ. Rhythm abnormalities of the fetus. Heart. 2007;93(10):1294-300. 49. Strasburger JF. Prenatal diagnosis of fetal arrhytmias. Clin Perinatol. 2005;32(4):891-912. 50. Yinon Y, Chitayat D, Blaser S, Seed M, Amsalem H, Yoo S, et al. Fetal cardiac tumors: a single-center experience of 40 cases. Prenat Diagn. 2010;30(10):941-9. 51. Zielinsky P, Busato S. Prenatal effects of maternal consumption of polyphenol-rich foods in late pregnancy upon fetal ductus arteriosus. Birth Defects Res C Embryo Today. 2013;99(4):256-74. 52. Volpe P, Marasini M, Caruso G, Lituania M, Marzullo A, Volpe G, et al. Prenatal diagnosis of ductus venosus agenesis and its association with cytogenetic/congenital anomalies. Prenat Diagn. 2002;22(11):995-1000. 53. Uzun O, Babaoglu K, Ayhan YI, Moselhi M, Rushworth F, Morris S, et al. Diagnostic ultrasound features and outcome of restrictive foramen ovale in fetuses with structurally normal hearts. Pediatr Cardiol. 2014;35(6):943-52. 54. Ayed A, Tonks AM, Lander A, Kilby MD. A review of pregnancies complicated by congenital sacrococcygeal teratoma in theWest Midlands region over an 18-year period: population-based, cohort study. Prenat Diagn. 2015;35(11):1037-47. 55. Hellmund A, Berg C, Bryan C, Schneider M, Hraška V, GembruchU. Large fetalpulmonaryarteriovenousmalformationdetectedatmidtrimesterscan with subsequent high cardiac output syndrome and favorable postnatal outcome. Fetal Diagn Ther. 2014;35(2):133-6. 56. Huhta JC. Fetal congestive heart failure. Semin Fetal Neonatal Med. 2005;10(6):542-52. 57. Berkley EM, Goens MB, Karr S, Rappaport V. Utility of fetal echocardiography in postnatal management of infants with prenatally diagnosed congenital heart disease. Prenat Diagn. 2009;29(7):654-8. 58. Johnson BA, Ades A. Delivery room and early postnatal management of neonates who have prenatally diagnosed congenital heart disease. Clin Perinatol. 2005;32(4):921-46. 59. Davey BT, Donofrio MT, Moon-Grady AJ, Fifer CG, Cuneo BF, Falkensammer CB, et al. Development and validation of a fetal cardiovasculardiseaseseverityscale.PediatrCardiol.2014;35(7):1174-80 60. Trevett TN Jr, Cotton J. Idiopathic constriction of the fetal ductus arteriosus. Ultrasound Obstet Gynecol. 2004;23(5):517-9. 61. Ho SY, Anderson RH. Anatomical closure of the ductus arteriosus: a study in 35 specimens. J Anat. 1979;128(Pt 4):829-36. 62. Tarcan A, Gurakan B, Yildirim S, Ozkiraz S, Bilezikci B. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure. J Perinat Med. 2004;32(1):98-9. 63. Babaoglu K, Cakiroglu Y, AltunG, Doger E, OguzD. Intrauterine idiopathic severe ductal constriction diagnosed by fetal echocardiography: a cause of hydrops fetalis. Anadolu Kardiyol Derg. 2013;13(5):496-7. 642